Hormonal status and ICU-acquired paresis in critically ill patients

Intensive Care Medicine

Volumn 36, Issue 8, 2010, Pages 1318-1326

  Sharshar, Tarek ^a   Bastuji Garin, Sylvie ^b   De Jonghe, Bernard ^a   Stevens, Robert D ^c   Polito, Andrea ^a   Maxime, Virginie ^a   Rodriguez, Pablo ^b   Cerf, Charles ^b   Outin, Hervé ^a   Touraine, Philippe ^d   Laborde, Kathleen ^e  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Critical illness neuromyopathy; Hormones; Mortality

Indexed keywords

ESTRADIOL; FOLLITROPIN; GLUCOSE; HYDROCORTISONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; SOMATOMEDIN; TESTOSTERONE; THYROTROPIN; HORMONE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ENDOCRINE DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOGONADISM; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARESIS; POSTMENOPAUSE; PROSPECTIVE STUDY; BLOOD; CROSS INFECTION; EPIDEMIOLOGY; FRANCE; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CROSS INFECTION; FEMALE; FRANCE; HORMONES; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PARESIS; PROSPECTIVE STUDIES;

EID: 77956175197     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-1840-6     Document Type: Article

References (29)

1. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I,Boussarsar M, Cerf C, Renaud E,Mesrati F, Carlet J, Raphaël JC, Outin H, Bastuji-Garin S (2002) Paralysisacquired in the intensive care unit: aprospective multicenter cohort study.JAMA 288:862-871
2. Ali NA, O'Brien JM Jr, Hoffmann SP,Phillips G, Garland A, Finley JC,Almoosa K, Hejal R, Wolf KM,Lemeshow S, Connors AF Jr, Marsh CB(2008) Acquired weakness, handgripstrength, and mortality in critically illpatients. Am J Respir Crit Care Med 178:261-268
3. Sharshar T, Bastuji-Garin S, Stevens RD, Durand MC, Malissin I, Rodriguez P, Cerf C, Outin H, De Jonghe B (2009)Presence and severity of intensive careunit-acquired paresis at time ofawakening are associated withincreased intensive care unit andhospital mortality*. Crit Care Med 37:3047-3053
4. De Jonghe B, Bastuji-Garin S, Durand M-C, Malissin I, Rodrigues P, Cerf C,Outin H, Sharshar T (2007) Respiratoryweakness is associated with limbweakness and delayed weaning incritical illness. Crit Care Med 35:2007-2015
5. Hermans G, Wilmer A, Meersseman W,Milants I, Wouters PJ, Bobbaers H,Bruynincks F, Van Den Berghe G (2007)Impact of intensive insulin therapy onneuromuscular complications andventilator dependency in medicalintensive care unit. Am J Respir Crit Care Med 175:480-489
6. Guarneri B, Bertolini G, Latronico N(2008) Long-term outcome in patientswith critical illness myopathy orneuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 79:838-841
7. Stevens RD, Dowdy DW, Michaels RK,Mendez-Tellez PA, Pronovost PJ,Needham DM (2007) Neuromusculardysfunction acquired in critical illness:a systematic review. Intensive Care Med 33:1876-1891
8. Vanhorebeek I, Langouche L, Van Den Berghe G (2006) Endocrine aspects ofacute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2:20-31
9. De Jonghe B, Finfer S (2007) Criticalillness neuromyopathy: from riskfactors to prevention. Am J Respir Crit Care Med 175:424-425
10. Le Gall JR, Lemeshow S, Saulnier F(1993) A new simplified acutephysiology score (SAPS II) based on a European/North American multicenterstudy. JAMA 270:2957-2963
11. Fagon JY, Chastre J, Novara A,Medioni P, Gibert C (1993)Characterization of intensive care unitpatients using a model based on thepresence or absence of organdysfunctions and/or infection: the ODIN model. Intensive Care Med 19:137-144
12. Bondanelli M, Zatelli MC, Ambrosio MR, Degli Uberti EC (2008) Systemicillness. Pituitary 11:11
13. Kleyweg RP, Van Der Meché FG,Schmitz PI (1991) Interobserveragreement in the assessment of musclestrength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14:1103-1109
14. Gebhart SS, Watts NB, Clark RV,Umpierrez G, Sgoutas D (1989)Reversible impairment of gonadotropinsecretion in critical illness.Observations in postmenopausalwomen. Arch Intern Med 149:1637-1641
15. Quint AR, Kaiser FE (1985)Gonadotropin determinations andthyrotropin-releasing hormone andluteinizing hormone-releasing hormonetesting in critically ill postmenopausalwomen with hypothyroxinemia. J Clin Endocrinol Metab 60:464-471
16. Timmins AC, Cotterill AM, Hughes SC, Holly JM, Ross RJ, Blum W, Hinds CJ (1996) Critical illness is associatedwith low circulating concentrations ofinsulin-like growth factors-I and-II,alterations in insulin-like growth factorbinding proteins, and induction of aninsulin-like growth factor bindingprotein 3 protease. Crit Care Med 24:1460-1466
17. Woolf PD, Hamill RW, Mc Donald JV,Lee LA, Kelly M (1985) Transienthypogonadotropic hypogonadismcaused by critical illness. J Clin Endocrinol Metab 60:444-450
18. Beishuizen A, Thijs LG, Vermes I(2002) Decreased levels ofdehydroepiandrosterone sulphate insevere critical illness: a sign ofexhausted adrenal reserve? Crit Care 6:434-438
19. Peeters RP, Wouters PJ, Van Toor H,Kaptein E, Visser TJ, Van Den Berghe G (2005) Serum 3,30,50-triiodothyronine(rT3) and 3,5,30-triiodothyronine/rT3are prognostic markers in critically illpatients and are associated withpostmortem tissue deiodinase activities.J Clin Endocrinol Metab 90:4559-4565
20. Van Den Berghe G, de Zegher F,Veldhuis JD, Wouters P, Gouwy S,Stockman W, Weekers F, Schetz M,Lauwers P, Bouillon R, Bowers CY(1997) Thyrotrophin and prolactinrelease in prolonged critical illness:dynamics of spontaneous secretion andeffects of growth hormonesecretagogues.Clin Endocrinol (Oxf)47:599-612
21. Noel GL, Suh HK, Stone JG, Frantz AG(1972) Human prolactin and growthhormone release during surgery andother conditions of stress. J Clin Endocrinol Metab 35:840-851
22. Faber J, Kirkegaard C, Rasmussen B,Westh H, Busch-Sorensen M, Jensen IW (1987) Pituitary-thyroid axis incritical illness. J Clin Endocrinol Metab 65:315-320
23. Meucci O, Landolfi E, Scorziello A,Grimaldi M, Ventra C, Florio T,Avallone A, Schettini G (1992)Dopamine and somatostatin inhibitionof prolactin secretion from MMQpituitary cells: role of adenosinetriphosphate-sensitive potassiumchannels. Endocrinology 131:1942-1947
24. Mesotten D, Van Den Berghe G (2006)Changes within the growth hormone/insulin-like growth factor I/IGF bindingprotein axis during critical illness.Endocrinol Metab Clin North Am 35:793-805 (ix-x)
25. Takala J, Ruokonen E, Webster NR,Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ (1999) Increased mortalityassociated with growth hormonetreatment in critically ill adults. N Engl J Med 341:785-792
26. Leijten FS, Harinck-de Weerd JE,Poortvliet DC, de Weerd AW (1995)The role of polyneuropathy in motorconvalescence after prolongedmechanical ventilation. JAMA 274:1221-1225
27. Ly LP, Jimenez M, Zhuang TN,Celermajer DS, Conway AJ,Handelsman DJ (2001) A double-blind,placebo-controlled, randomized clinicaltrial of transdermal dihydrotestosteronegel on muscular strength, mobility, andquality of life in older men with partialandrogen deficiency. J Clin Endocrinol Metab 86:4078-4088
28. Nair KS, Rizza RA, O'Brien P,Dhatariya K, Short KR, Nehra A,Vittone JL, Klee GG, Basu A, Basu R,Cobelli C, Toffolo G, Dalla Man C,Tindall DJ, Melton LJ III, Smith GE,Khosla S, Jensen MD (2006) DHEA inelderly women and DHEA ortestosterone in elderly men. N Engl JMed 355:1647-1659
29. Kaaja RJ (2008) Metabolic syndromeand the menopause. Menopause Int 14:21-25